Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody

Canakinumab is a high-affinity human monoclonal anti-interleukin-1β (IL-1β) antibody of the IgG1/κ isotype designed to bind and neutralize the activity of human IL-1β, a pro-inflammatory cytokine. Canakinumab is currently being investigated on the premise that it would exert anti-inflammatory effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakraborty, Abhijit, Tannenbaum, Stacey, Rordorf, Christiane, Lowe, Philip J., Floch, David, Gram, Hermann, Roy, Sandip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584253/
https://www.ncbi.nlm.nih.gov/pubmed/22550964
http://dx.doi.org/10.2165/11599820-000000000-00000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584253/
https://www.ncbi.nlm.nih.gov/pubmed/22550964
http://dx.doi.org/10.2165/11599820-000000000-00000

Ejemplares similares